NCT00280852CompletedNot Applicable
A Retrospective Review of Multimodality Management of Anaplastic Thyroid Cancer
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Alberta Health services
- Enrollment
- 5
- Locations
- 1
Study Overview
Brief Summary
To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
Study Design
- Study Type
- Observational
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •anaplastic thyroid cancer treated with multimodality treatment
Exclusion Criteria
- •differentiated thyroid cancer
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Multimodality Treatment Including Curative Resection of Advanced NSCLCAdvanced Non-small-cell Lung CancerNCT04455984Medical University of Vienna190
Completed
Phase 3
rhTSH for Radioactive Iodine Remnant Ablation in Participants With Differentiated Thyroid Cancer (DTC)Differentiated Thyroid CancerNCT04964284Suzhou Zelgen Biopharmaceuticals Co.,Ltd390
Completed
Phase 3
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.Differentiated Thyroid CancerNCT00295763Genzyme, a Sanofi Company61
Active, not recruiting
Not Applicable
ew therapeutic approaches for anaplastic thyroid cancer: assessment of the benefit-risk profile of the combination valproic acid-paclitaxel. - NDEUCTR2008-005221-11-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Unknown
Phase 2
A phase II study for anaplastic thyroid canceranaplastic thyroid cancerJPRN-UMIN000000482agoya university hospital20